health - "cancer"

New data on whether the popular cholesterol drugs Zetia and Vytorin increase risk of cancer will be one of the highlights of a huge European conference of heart specialists opening Saturday.

HealthDay - FRIDAY, Aug. 29 (HealthDay News) -- Some Japanese survivors ofthe World War II atomic bomb blasts in Hiroshima and Nagasaki experiencedkey genetic changes that may have sparked the onset of a form of thyroidcancer, new research indicates.

There are many trials and tribulations that come when women find out they have breast cancer, but one of the things women fear most is losing their hair during chemotherapy treatments. Now, one Manhattan salon is helping cancer patients rebuild their self-confidence.

A teenage cancer patient has undergone successful surgery to rebuild his shoulder using his elbow.

NEW YORK (Reuters Health) - Women who stay active after being diagnosed with breast cancer -- and even those who take up exercise for the first time after diagnosis -- have a better chance of surviving the disease, a new study shows.

NEW YORK (Reuters Health) - A high intake of trans fats could increase colon cancer risk, according to new research published in the American Journal of Epidemiology.

Women who stay active after being diagnosed with breast cancer -- and even those who take up exercise for the first time after diagnosis -- have a better chance of surviving the disease, a new study shows.

A high intake of trans fats could increase colon cancer risk, according to new research published in the American Journal of Epidemiology.

ImClone Systems Inc said on Friday that a trial of its cancer drug Erbitux did not significantly improve overall survival in a trial of patients with the most common form of lung cancer.

Medicare overpaid for irinotecan, a cancer drug sold by Pfizer under the name Campostar, by $6.5 million in March because of a delay in updating its pricing formula, according to a report released on Tuesday by the HHS Office of Inspector General, Bloomberg/Los Angeles Times reports. A generic version of the drug was approved for sale on Feb. 20.